Skip to main content

MoneyWorks4Me

The sales for the September 2026 quarter moved up 37.13% to Rs. 5144.96 millions as compared to Rs. 3751.87 millions during the corresponding quarter last year.The Net Profit of the company reported a remarkable increase of 132.32% to Rs. 861.92  millions  from Rs. 371.01 millions in previous same quarter.Operating Profit saw a handsome growth to 1594.16 millions from 1046.16 millions in the quarter ended September 2026.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202609 202509 % Var 202609 202509 % Var 202603 202503 % Var
Sales 5144.96 3751.87 37.13 9609.67 6961.99 38.03 14053.81 12995.89 8.14
Other Income 9.23 30.36 -69.60 47.10 82.91 -43.19 150.08 176.82 -15.12
PBIDT 1594.16 1046.16 52.38 2773.35 1897.46 46.16 2840.01 3869.57 -26.61
Interest 341.81 333.08 2.62 646.98 603.39 7.22 1205.76 1616.50 -25.41
PBDT 1252.35 713.08 75.63 2126.37 1294.07 64.32 1580.05 1130.57 39.76
Depreciation 390.43 342.07 14.14 752.20 674.91 11.45 1367.95 1345.12 1.70
PBT 861.92 371.01 132.32 1374.17 619.16 121.94 212.10 -214.55 -198.86
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -414.55 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -414.55 0.00
PAT 861.92 371.01 132.32 1374.17 619.16 121.94 212.10 200.00 6.05
Equity 114.67 114.52 0.13 114.67 114.52 0.13 114.62 114.43 0.17
PBIDTM(%) 30.98 27.88 11.12 28.86 27.25 5.89 20.21 29.78 -32.13
Peers
Company Name CMP
Sun Pharma. Inds. 1758.00
Dr. Reddys Labs. 1335.40
Cipla 1360.00
Lupin 1971.00
Zydus Lifesciences 1172.00
View more..